Jyh‐Pyng Gau

1.0k total citations
74 papers, 659 citations indexed

About

Jyh‐Pyng Gau is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jyh‐Pyng Gau has authored 74 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 25 papers in Oncology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Jyh‐Pyng Gau's work include Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). Jyh‐Pyng Gau is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). Jyh‐Pyng Gau collaborates with scholars based in Taiwan, United States and United Kingdom. Jyh‐Pyng Gau's co-authors include Liu H, Yuan‐Bin Yu, Liang‐Tsai Hsiao, Hui‐Chi Hsu, Chao‐Hung Ho, Wing‐Keung Chau, Yao‐Chung Liu, Po‐Min Chen, Cheng‐Hwai Tzeng and Tzeon‐Jye Chiou and has published in prestigious journals such as Blood, Neurology and International Journal of Cancer.

In The Last Decade

Jyh‐Pyng Gau

68 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jyh‐Pyng Gau Taiwan 14 277 158 120 105 95 74 659
Martin Mohren Germany 17 321 1.2× 188 1.2× 98 0.8× 91 0.9× 170 1.8× 37 936
Jeffrey A. Vos United States 12 157 0.6× 168 1.1× 95 0.8× 167 1.6× 48 0.5× 40 797
Francesco Dragoni Italy 15 210 0.8× 141 0.9× 73 0.6× 93 0.9× 136 1.4× 28 589
Liang-Tsai Hsiao Taiwan 15 199 0.7× 260 1.6× 65 0.5× 400 3.8× 77 0.8× 50 894
Christoph Sucker Germany 15 224 0.8× 64 0.4× 105 0.9× 90 0.9× 62 0.7× 83 834
Suman L. Sood United States 16 375 1.4× 59 0.4× 103 0.9× 101 1.0× 77 0.8× 52 871
Tienan Zhu China 11 163 0.6× 64 0.4× 88 0.7× 52 0.5× 50 0.5× 55 576
N. Magy‐Bertrand France 16 247 0.9× 48 0.3× 82 0.7× 178 1.7× 56 0.6× 97 970
Andrei Braester Israel 13 84 0.3× 129 0.8× 79 0.7× 43 0.4× 190 2.0× 63 625
H. Desmurs‐Clavel France 12 201 0.7× 57 0.4× 69 0.6× 63 0.6× 41 0.4× 21 832

Countries citing papers authored by Jyh‐Pyng Gau

Since Specialization
Citations

This map shows the geographic impact of Jyh‐Pyng Gau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyh‐Pyng Gau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyh‐Pyng Gau more than expected).

Fields of papers citing papers by Jyh‐Pyng Gau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyh‐Pyng Gau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyh‐Pyng Gau. The network helps show where Jyh‐Pyng Gau may publish in the future.

Co-authorship network of co-authors of Jyh‐Pyng Gau

This figure shows the co-authorship network connecting the top 25 collaborators of Jyh‐Pyng Gau. A scholar is included among the top collaborators of Jyh‐Pyng Gau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyh‐Pyng Gau. Jyh‐Pyng Gau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jong Wook, Jun Ho Jang, Hirohito Yamazaki, et al.. (2025). Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood Advances. 9(22). 5732–5735. 1 indexed citations
2.
Yang, Ching‐Fen, Liang‐Tsai Hsiao, Po‐Shen Ko, et al.. (2023). Long‐term outcomes of frontline intensification in primary CNS lymphoma: A real‐world single‐center experience. Cancer Medicine. 12(7). 8089–8101. 3 indexed citations
3.
Gau, Jyh‐Pyng, et al.. (2023). Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair Study. Clinical Medicine Insights Oncology. 17. 1373324102–1373324102. 1 indexed citations
4.
Tsai, Cheng‐Hong, Tzu‐Ting Chen, Jyh‐Pyng Gau, et al.. (2022). Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry. Cancers. 14(4). 1097–1097. 7 indexed citations
5.
Yeh, Chiu‐Mei, Yao‐Chung Liu, Hao‐Yuan Wang, et al.. (2022). Herpes zoster prophylaxis: Essential for treating newly diagnosed multiple myeloma patients. Cancer Medicine. 12(3). 3013–3026. 1 indexed citations
6.
Kuo, Ming‐Chung, Chien‐Chin Lin, Hsuan-Yu Lin, et al.. (2022). Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan. Blood. 140(Supplement 1). 9709–9710.
7.
8.
Chen, Chien‐Ting, et al.. (2018). Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia. Journal of the Chinese Medical Association. 81(12). 1038–1043. 11 indexed citations
9.
Liu, Yao‐Chung, Po‐Shen Ko, Hao‐Yuan Wang, et al.. (2017). Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome. Blood. 130. 4527–4527. 1 indexed citations
10.
Chien, Sheng‐Hsuan, Yao‐Chung Liu, Chia-Jen Liu, et al.. (2016). Invasive Mold Infections in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 128(22). 3434–3434. 1 indexed citations
11.
Liu, Yao‐Chung, Sheng‐Hsuan Chien, Jyh‐Pyng Gau, et al.. (2015). Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. Journal of Microbiology Immunology and Infection. 49(4). 567–574. 33 indexed citations
12.
Hsiao, Liang‐Tsai, Tzeon-Jye Chiou, Jyh‐Pyng Gau, et al.. (2015). Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients. Medicine. 94(32). e1321–e1321. 13 indexed citations
13.
Lin, Ting‐Wei, Jyh‐Pyng Gau, Yuan‐Bin Yu, et al.. (2015). Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma. Medicine. 94(50). e2305–e2305. 38 indexed citations
14.
Hsiao, Liang‐Tsai, Tzeon‐Jye Chiou, Chun‐Yu Liu, et al.. (2010). Comorbid Diabetes Does Not Impact the Survival of Patients with Multiple Myeloma. Blood. 116(21). 5003–5003. 1 indexed citations
15.
Li, Chunyi, Chih‐Cheng Chen, Jie‐Yu You, et al.. (2007). Combined Treatment with Splenectomy and Cladribine in Hairy Cell Leukemia in Taiwan: A Clinicopathologic Study of 5 Cases. Journal of the Chinese Medical Association. 70(12). 551–555. 3 indexed citations
16.
Hsu, Hui‐Chi, et al.. (2006). Cost Effectiveness of Post-Remission Intensive Therapy in Patients with Acute Leukemia.. Blood. 108(11). 5522–5522.
17.
Ho, Chao‐Hung, Benjamin Ing-Tiau Kuo, Chi‐Woon Kong, et al.. (2005). Influence of Methylenetetrahydrofolate Reductase ( MTHFR ) C677T Polymorphism, B Vitamins and Other Factors on Plasma Homocysteine and Risk of Thromboembolic Disease in Chinese. Journal of the Chinese Medical Association. 68(12). 560–565. 19 indexed citations
18.
Wang, Jyh‐Chwan, et al.. (1996). Prenatal and molecular diagnosis of hemophilia B. American Journal of Hematology. 52(4). 243–247. 1 indexed citations
19.
Gau, Jyh‐Pyng, et al.. (1994). Isolated Extramedullary Relapse of Acute Lymphoblastic Leukemia Presenting as an Intraspinal Mass. Acta Haematologica. 91(1). 46–48. 10 indexed citations
20.
Hwang, Wen‐Li, et al.. (1992). Ketoconazole and High-Dose Methylprednisolone Predisposing to Cyclosporine-lnduced Seizures: Report of 3 Cases. Acta Haematologica. 88(2-3). 139–141. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Mohren Breakdown of academic impact, for papers by Jeffrey A. Vos Breakdown of academic impact, for papers by Francesco Dragoni Breakdown of academic impact, for papers by Liang-Tsai Hsiao Breakdown of academic impact, for papers by Christoph Sucker Breakdown of academic impact, for papers by Suman L. Sood Breakdown of academic impact, for papers by Tienan Zhu Breakdown of academic impact, for papers by N. Magy‐Bertrand Breakdown of academic impact, for papers by Andrei Braester Breakdown of academic impact, for papers by H. Desmurs‐Clavel
Rankless by CCL
2026